Clinical trial
Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell…
NCT00003200 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003200 |
|---|---|
| Title | Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck |
| Official title | Taxotere Plus Concurrent Radiotherapy After Induction Chemotherapy for Squamous Cell Carcinoma of the Head and Neck (TAXT-XRT) |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Taxotere, Radiation therapy |
| Enrollment | 22 |
| Start date | Oct 1, 1995 |
| Primary completion | Oct 1, 2006 |
| Completion | Jun 1, 2008 |
| First posted | Aug 13, 2004 |
| Last update posted | Jan 19, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: